NB-PP_1170x120

diabetes

Noninvasive technologies help battle diabetes and NAFLD

Noninvasive technologies help battle diabetes and NAFLD

The American Liver Foundation estimates that over 30% of the U.S. population has some degree of nonalcoholic fatty liver disease (NAFLD), the most common type of liver disease in the Western world. This can impact other facets of their overall health, because NAFLD has been linked to diabetes, obesity, insulin resistance and other metabolic risk

NACDS hails pharmacists’ role in diabetes management and prevention

NACDS hails pharmacists’ role in diabetes management and prevention

ARLINGTON, Va. – A National Association of Chain Drug Stores ) op-ed published by Morning Consult today describes the role of community pharmacy practice and of NACDS members’ philanthropic initiatives in helping to prevent and manage diabetes. “Two of the central areas where pharmacies and pharmacists have the greatest impact in diabetes are medication management and behavior change

Lilly presents new diabetes data at ADA session

Lilly presents new diabetes data at ADA session

ORLANDO, Fla. — Eli Lilly’s ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from three phase 1b studies evaluating URLi compared to Humalog. URLi is Lilly’s novel mealtime insulin currently in phase 3 development. The data was presented in

Study to probe Jardiance effects on kidney disease

Study to probe Jardiance effects on kidney disease

RIDGEFIELD, Conn. and INDIANAPOLIS — Boehringer Ingelheim and Eli Lilly and Co.  yesterday announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance on the progression of kidney disease and the occurrence of cardiovascular death, in adults with established chronic kidney disease with and without diabetes. EMPA-KIDNEY will be independently conducted, analyzed and reported by the Medical

Sanofi insulin savings program aims to cut costs

Sanofi insulin savings program aims to cut costs

BRIDGEWATER, N.J. — Sanofi’s new Insulins VALyou Savings Program will seek to help lower out-of-pocket costs for people living with diabetes who otherwise would pay full retail price for Lantus or Admelog. This includes certain uninsured patients who don’t qualify for traditional patient assistance programs, in addition to some commercially insured patients with a high

Hy-Vee broadens diabetes program

Hy-Vee broadens diabetes program

WEST DES MOINES, Iowa — Midwestern retailer Hy-Vee is enhancing its diabetes programs with Begin for Diabetes, a lifestyle management program designed for the unique set of health and nutrition challenges those dealing with the disease face. The program, which the company just launched, adds to Hy-Vee’s existing Begin and Begin 4 Kids programs. All three diabetes

Perrigo rolls out store-brand Glucerna shake

Perrigo rolls out store-brand Glucerna shake

DUBLIN, Ireland — Perrigo Co. plc has begun shipping a store-brand version of Abbott’s Glucerna aseptic nutritional shake for adults with diabetes. Perrigo said Tuesday that its product represents a first-to-market launch of an over-the-counter, private-brand equivalent to Glucerna. The company said its product is packaged and marketed as a store brand or retailer “own

Novo Nordisk buys pair of biopharma companies

Novo Nordisk buys pair of biopharma companies

BAGSVAERD, Denmark — Novo Nordisk plans to acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Carmel, Ind. The Danish pharmaceutical company said Thursday that the acquisition will expand its portfolio of projects and intellectual property rights in the diabetes and obesity segments and help expand Novo Nordisk’s research presence

Walgreens loyalty plan promotes health

DEERFIELD, Ill. — Walgreen Co. says that its Balance Rewards for healthy choices (BRhc) program, which awards loyalty points for healthy behaviors and activities, is helping members lose weight and driving better medication adherence among participants with hypertension and/or diabetes. According to a new white paper and outcomes data the company released, active members who

Lilly marks a first with Humalog U-200 KwikPen

Lilly marks a first with Humalog U-200 KwikPen

INDIANAPOLIS — Eli Lilly and Co. has been cleared by the Food and Drug Administration to market the Humalog 200 units/ml KwikPen, which the company called the first concentrated mealtime insulin analog approved in the United States. Lilly said Wednesday that the Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml, U-200) is a prefilled pen

Nipro set to launch True Metrix Air

Nipro set to launch True Metrix Air

FORT LAUDERDALE, Fla. — Nipro Diagnostics Inc. has gained approval from the Food and Drug Administration for the True Metrix Air Self-Monitoring blood glucose system, which enables people with diabetes to test blood glucose and deliver data wirelessly to a smartphone. Nipro said Friday that the True Metrix Air will be available starting in the